Home PamBio

PamBio

In operation
Series A
Research on the Treatment of Hemorrhagic Stroke
Basic
Enterprise Profile

Basic Information

PamBio is a biotech startup dedicated to researching treatments for hemorrhagic stroke (i.e., bleeding or rupture of blood vessels in the brain). They aim to prevent cerebral hemorrhage in patients and protect the brain from damage — which is the most painful sequela for the majority of stroke sufferers. PamBio strives to halt acute bleeding during the stroke process.
PamBio
NorthernDistrict,Israel
less than 15 people
May 01, 2014
Amos@pambio.co.il

Enterprise Profile

Industrial Sector
Scientific Research and Experimental Development Services
Technology
Gene Technology Biotechnology
Concept
Cerebrovascular Disease (Stroke)